LLY Earnings: Stock Barely Budges, but What Does History Tell Us About the Next Move?


Re-Tweet
Share on LinkedIn

Eli Lilly posted robust Q3 results, but the stock's immediate move post-earnings has historically been a toss-up. We dig into the numbers and explore what the data suggests about short-term and post-earnings trends.
Click to view the earnings moves in LLY

Did Wall Street Miss the Mark on Eli Lilly’s Post-Earnings Move?

With expectations sky-high, Eli Lilly and Company (LLY) announced third-quarter 2025 results that impressed on nearly every front—revenue soared 54%, earnings per share (EPS) ballooned, and guidance for the rest of the year got a healthy boost. Yet, in the immediate aftermath, the stock ticked up just 1.1%—well below the ±5.6% move that options traders were betting on. Was the market unimpressed, or does history tell a different story?

LLY’s Earnings: Big Results, Measured Reaction

This quarter’s highlights include explosive sales of Mounjaro and Zepbound, a bumper $17.6 billion in revenue, and a series of major pipeline and regulatory wins. With options volume hitting 4,512 contracts, expectations were clearly running high.

Despite all that momentum, today’s stock move is, on the surface, underwhelming. The previous earnings release even saw LLY plunge 14.1%, a reminder of how volatile earnings reactions can be. So how unusual is a flat or muted post-earnings response for LLY?

Historical Patterns: A 50/50 Earnings Gamble?

Looking back over the last 12 quarters, LLY’s immediate reaction to earnings has been essentially a coin toss: the stock averages just a +0.1% return, with a dead-even 50% chance of moving up or down. While the initial opening gap (from previous close to open) is a touch more positive (+0.8%), the odds are only slightly better for bulls (58.3% upside gaps).

Interestingly, the stock has often given up early gains: from the open to close, LLY actually averages a -0.7% decline, and nearly 60% of the time, the stock drifts lower during the day—even if the open is strong. Swings can be sizable: the average drop to the day's low is -3.5%, with a high of +2.5% on the upside. If you're thinking of trading the initial reaction, keep in mind this intraday bias to the downside.

Stock Performance Earnings Move Open Gap Open to High Open to Low Open to Close
Average Return +0.1% +0.8% +2.5% -3.5% -0.7%
% of Moves Up 50.0% 58.3% 41.7%
% of Moves Down 50.0% 41.7% 58.3%

If you’re interested in more granular statistics (including absolute moves and min/max reactions), the full data set is available on this earnings stats page.

Stock Performance Earnings Move Open Gap Open to High Open to Low Open to Close
Absolute Average Return 6.4% 5.9% 2.5% 3.5% 3.2%
Max Absolute Return 14.9% 13.1% 7.8% 6.4% 6.1%
Min Absolute Return 0.2% 0.2% 0.4% 0.2% 0.1%

Post-Earnings: Patience May Pay Off

While the day-of earnings action can be choppy and directionless, LLY actually shines in the aftermath. Historically, the stock averages a +1.2% gain the day after earnings, rising nearly three-quarters of the time (72.7%). One week out, that gain grows to +3.2%, with similar win rates, and at two weeks, LLY has historically been up +4.2% with nearly two-thirds of post-earnings periods positive.

Stock Performance 1 Day After Earnings 2 Days After Earnings 3 Days After Earnings 1 Week After Earnings 2 Weeks After Earnings
Average Return +1.2% +1.4% +0.8% +3.2% +4.2%
% of Moves Up 72.7% 54.5% 54.5% 72.7% 63.6%
% of Moves Down 27.3% 45.5% 45.5% 27.3% 36.4%

What Should Traders Watch Next?

LLY’s fundamentals look undeniably strong, but the options market may have overestimated the immediate volatility this time. Still, with a robust track record of gains in the days and weeks after earnings—even when day-of reactions are muted—the data suggests patience could be key. Keep an eye on continued demand for its obesity and diabetes franchises, as well as the next pipeline announcements and manufacturing ramp-ups, as potential catalysts.

For more on Eli Lilly’s historical earnings-day performance, you can dive into the details here.


Contact Information:

If you have feedback or concerns about the content, please feel free to reach out to us via email at support@marketchameleon.com.


About the Publisher - Marketchameleon.com:

Marketchameleon is a comprehensive financial research and analysis website specializing in stock and options markets. We leverage extensive data, models, and analytics to provide valuable insights into these markets. Our primary goal is to assist traders in identifying potential market developments and assessing potential risks and rewards.


NOTE: Stock and option trading involves risk that may not be suitable for all investors. Examples contained within this report are simulated and may have limitations. Average returns and occurrences are calculated from snapshots of market mid-point prices and were not actually executed, so they do not reflect actual trades, fees, or execution costs. This report is for informational purposes only, and is not intended to be a recommendation to buy or sell any security. Neither Market Chameleon nor any other party makes warranties regarding results from its usage. Past performance does not guarantee future results. Please consult a financial advisor before executing any trades. You can read more about option risks and characteristics at theocc.com.


The information is provided for informational purposes only and should not be construed as investment advice. All stock price information is provided and transmitted as received from independent third-party data sources. The Information should only be used as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments and trading strategies. The Company does not guarantee the accuracy, completeness or timeliness of the Information.


Disclosure: This article was generated with the assistance of AI

Market Data Delayed 15 Minutes